Brief: AB Science Announces Promising Results Of Phase 3 Study Of Alzheimer-Treating Drug

AB Science SA

29/07/2021 18:20

July 29 (Reuters) - AB Science SA  ABS.PA :
    * ANNOUNCED THAT RESULTS FROM ITS PHASE 3 AB09004 STUDY ON
MILD TO
MODERATE ALZHEIMER’S DISEASE HAVE BEEN PRESENTED AT THE AAIC
    * MASITINIB ADMINISTERED AT 4.5 MG/KG/DAY,SIGNIFICANTLY
SLOWED
COGNITIVE DETERIORATION RELATIVE TO PLACEBO
    * DATA SHOWED REDUCED LOSS OF FUNCTIONAL ABILITY IN
ACTIVITIES OF
DAILY LIVING

Source text for Eikon:  ID:nGNE8CntPP 
Further company coverage:  ABS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))